Core Scientific (NASDAQ:CORZ) Receives Buy Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of Core Scientific (NASDAQ:CORZFree Report) in a report issued on Tuesday morning,Benzinga reports. HC Wainwright currently has a $25.00 target price on the stock.

CORZ has been the subject of several other reports. Zacks Research upgraded Core Scientific from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 13th. Sanford C. Bernstein lifted their target price on Core Scientific from $17.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, November 3rd. Citigroup raised shares of Core Scientific from a “market perform” rating to an “outperform” rating in a research report on Thursday, December 18th. Citizens Jmp raised shares of Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 price target on the stock in a research report on Thursday, December 18th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Core Scientific in a research note on Wednesday, January 21st. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $24.66.

View Our Latest Report on Core Scientific

Core Scientific Price Performance

Core Scientific stock opened at $15.30 on Tuesday. The company’s 50-day moving average is $17.27 and its 200-day moving average is $16.96. The firm has a market capitalization of $4.74 billion, a PE ratio of 13.08 and a beta of 6.87. Core Scientific has a fifty-two week low of $6.20 and a fifty-two week high of $23.63.

Core Scientific (NASDAQ:CORZGet Free Report) last posted its quarterly earnings results on Monday, March 2nd. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.69. The business had revenue of $79.76 million during the quarter, compared to the consensus estimate of $118.45 million. The firm’s revenue was down 16.0% on a year-over-year basis. During the same quarter last year, the company posted ($0.69) EPS. As a group, analysts expect that Core Scientific will post 0.52 EPS for the current year.

Hedge Funds Weigh In On Core Scientific

Hedge funds and other institutional investors have recently made changes to their positions in the company. AQR Capital Management LLC grew its position in Core Scientific by 106.1% during the 1st quarter. AQR Capital Management LLC now owns 283,432 shares of the company’s stock worth $2,052,000 after acquiring an additional 145,905 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Core Scientific by 180.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,109,387 shares of the company’s stock valued at $8,032,000 after purchasing an additional 714,388 shares in the last quarter. Nisa Investment Advisors LLC grew its holdings in shares of Core Scientific by 192.3% during the second quarter. Nisa Investment Advisors LLC now owns 4,662 shares of the company’s stock worth $80,000 after purchasing an additional 3,067 shares during the last quarter. Teacher Retirement System of Texas grew its holdings in shares of Core Scientific by 31.4% during the second quarter. Teacher Retirement System of Texas now owns 42,543 shares of the company’s stock worth $726,000 after purchasing an additional 10,161 shares during the last quarter. Finally, Amalgamated Bank increased its stake in shares of Core Scientific by 52.2% in the second quarter. Amalgamated Bank now owns 9,423 shares of the company’s stock valued at $161,000 after buying an additional 3,231 shares during the period.

Key Core Scientific News

Here are the key news stories impacting Core Scientific this week:

  • Positive Sentiment: Unusually large options activity — traders bought ~188,642 call options (≈51% above normal call volume), signalling aggressive bullish positioning from some market participants.
  • Positive Sentiment: Colocation revenue surge — management reported colocation revenue grew dramatically (reported +268% year-over-year), supporting the company’s transition from BTC mining toward AI/colocation demand. Core Scientific Colocation Revenue Surges 268% Amid Mixed Q4 Results
  • Positive Sentiment: Analyst upgrades and high targets — Needham upgraded CORZ to Buy with a $23 target (~+50% implied upside), HC Wainwright reaffirmed Buy with $25, and Cantor Fitzgerald kept an Overweight with a $25 target; these actions reinforce a bullish analyst tone despite some target trims. Needham Upgrade
  • Neutral Sentiment: Mixed quarter — CORZ reported $0.42 EPS (beat consensus) but revenue of $79.8M missed estimates (~$118M), so profitability signals improved while top-line momentum is weak; management emphasized progress on a 1.5 GW leasable pipeline. Business Wire: Q4 Results
  • Neutral Sentiment: Full disclosure and detail sources — earnings slide deck and call transcript are available for investors who want to dig into guidance, margin dynamics, and contract backlog. Earnings Presentation
  • Negative Sentiment: Revenue miss and reported loss — some outlets highlight the Q4 revenue miss and a quarterly loss (Zacks coverage), raising near-term concern about top-line pacing while the company reinvests for AI/colocation growth. Zacks: Q4 Loss, Revenue Miss
  • Negative Sentiment: Immediate market reaction — coverage notes CORZ shares slid after the report and as the company pushes a sizable infrastructure expansion (1.5 GW), highlighting investor worry about near-term cash burn and execution risk. Blockonomi: Stock Slides
  • Neutral Sentiment: Short-interest data appears unreliable in recent feeds (showing zeros/NaN); no clear short-squeeze signal from public short-interest figures at this time.

About Core Scientific

(Get Free Report)

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.

See Also

Analyst Recommendations for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.